Literature DB >> 5120302

Differential effects of melphalan on mouse myeloma (adj. PC-5) and hemopoietic stem cells.

M Ogawa, D E Bergsagel, E A McCulloch.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5120302

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  6 in total

1.  Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas.

Authors:  Francesca Boscolo Sesillo; Alessandra Sacco
Journal:  J Vis Exp       Date:  2019-09-13       Impact factor: 1.355

2.  In vitro myelosuppression and immunosuppression by ethanol.

Authors:  G Tisman; V Herbert
Journal:  J Clin Invest       Date:  1973-06       Impact factor: 14.808

3.  Primary bioassay of human myeloma stem cells.

Authors:  A Hamburger; S E Salmon
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

Review 4.  The human tumor cloning assay in cancer drug development. A review.

Authors:  P Agre; T E Williams
Journal:  Invest New Drugs       Date:  1983       Impact factor: 3.850

Review 5.  [Predictive tumor tests in chemotherapeutic treatment concepts of malignant diseases].

Authors:  K Possinger; H Ehrhart
Journal:  Klin Wochenschr       Date:  1983-01-17

6.  Non-invasive imaging provides spatiotemporal information on disease progression and response to therapy in a murine model of multiple myeloma.

Authors:  Simone S Riedel; Anja Mottok; Christian Brede; Carina A Bäuerlein; Ana-Laura Jordán Garrote; Miriam Ritz; Katharina Mattenheimer; Andreas Rosenwald; Hermann Einsele; Bjarne Bogen; Andreas Beilhack
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.